TMCnet News

Gene Expression Analysis Market 2017: Rising Demand For Targeted Molecular Therapeutics - Research and Markets
[October 17, 2017]

Gene Expression Analysis Market 2017: Rising Demand For Targeted Molecular Therapeutics - Research and Markets


The "Gene Expression Analysis Market, 2014-2025" report has been added to Research and Markets' offering.

The global gene expression market is expected to reach USD 11.3 billion by 2025. Globally, the rising demand for targeted molecular therapeutics coupled with rising adoption of precision medicine is anticipated to fuel market growth.

Understanding gene expression under different conditions as well as the effects it has on different metabolic activities has opened various vistas for the development of a novel generation of molecular therapeutics. Search for methods to manipulate the way a coding DNA is expressed as a cure to different conditions arising due to abnormally expressed genes is expected to drive market.

Target (News - Alert) expression analysis and single cell analysis using low- to mid- plex techniques to identify smallest differences and correlations in gene expression. Novel products focusing on with improved efficiency and reliability are launched for smaller samples. Increased interest stem cell and gene therapy are projected to propel revenue generation for the market.

Emerging NGS technologies coupled with their drastically declining prices are anticipated to boost adopton of gene expression techniques. Furthermore, government support through initiatives such as Precision Medicine Initiative would encourage private investments in the sector leading to market growth.



Drug discovery and development was estimated with largest share owing to higher adoption in drug response testing for severs and complicated diseases such as all types of cancer, tuberculosis, cardiac conditions and rare genetic disorders. However, clinical diagnostic application is projected with fastest growth owing to rising demand for rapid and accurate diagnosis of complex diseases coupled with their higher incidence.

Companies Mentioned


  • Quest Diagnostics Incorporated.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Novogene Corporation.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • Life Technologies Corporation
  • Affymetrix, Inc.
  • Agilent (News - Alert) Technologies
  • GE Healthcare Dharmacon Inc.
  • AutoGenomics
  • Biocartis Group NV
  • IntegraGen.
  • Interpace Diagnostics, LLC.
  • Others

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Gene Expression Analysis Market Variables, Trends & Scope

Chapter 4 Gene Expression: Process Estimates & Trend Analysis

Chapter 5 Gene Expression: Product Estimates & Trend Analysis

Chapter 6 Gene Expression: Capacity Estimates & Trend Analysis

Chapter 7 Gene Expression: Technique Estimates & Trend Analysis

Chapter 8 Gene Expression: Application Estimates & Trend Analysis

Chapter 9 Gene Expression: Regional Estimates & Trend Analysis, by Process, Product, Capacity, Technique & Application

Chapter 10 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/836ndw/gene_expression


[ Back To TMCnet.com's Homepage ]